BioCentury | Dec 10, 2019
Finance

Perceptive launches $210M early-stage fund tied to Garabedian’s accelerator Xontogeny

Two and a half years after Perceptive Advisors’ Chris Garabedian launched Xontogeny to foster biotech start-ups’ growth, the firm has created a $210 million fund that will invest in companies the accelerator is nurturing through...
BC Extra | Aug 14, 2019
Financial News

$60M B round to propel Landos through Phase II IBD trials

Landos' $60 million series B will enable it to complete two Phase II trials, one each in ulcerative colitis and Crohn's disease, of lead product BT-11. Chairman, President and CEO Josep Bassaganya-Riera told BioCentury he...
Emerging Company Profile | Apr 20, 2018
Emerging Company Profile

Clear for Landos

Landos Biopharma Inc. is developing a first-in-class LANCL2 agonist designed to provide improved convenience, efficacy and safety over standard-of-care therapies for inflammatory bowel disease (IBD), including moderate to severe Crohn’s disease (CD) and ulcerative colitis...
BC Week In Review | Sep 22, 2017
Financial News

Landos spins out of Xontogeny accelerator

On Sept. 21, Landos Biopharma Inc. (Blacksburg, Va.) spun out of life sciences accelerator Xontogeny LLC (Boston, Mass) with the first $5 million tranche of a $10 million series A round from Perceptive Advisors. CEO...
BC Extra | Sep 21, 2017
Financial News

Landos spins out of Xontogeny accelerator

Landos Biopharma Inc. (Blacksburg, Va.) spun out of life sciences accelerator Xontogeny LLC (Boston, Mass) and raised the first $5 million tranche of a $10 million series A round from Perceptive Advisors. CEO Josep Bassaganya-Riera...
BC Week In Review | May 24, 2004
Clinical News

Bt-11 sweet corn regulatory update

The EC authorized the marketing of Bt-11 sweet corn from SYNN as canned or fresh food. The decision, which is valid for 10 years, does not include the approval of Bt-11 sweet corn for cultivation...
BioCentury | May 24, 2004
Politics, Policy & Law

EU gags on patents, goes for the corn

Despite the opposition of several member states, the EU Commission last week ended an almost six-year moratorium on GMOs by authorizing the import and marketing of Syngenta International AG's Bt-11 corn for human consumption. The...
BC Extra | May 19, 2004
Company News

EU approves import of GM corn for food

The European Commission authorized the marketing of Bt-11 sweet corn from Syngenta (SWX:SYNN; SYT) as canned or fresh food. The decision, which is valid for 10 years, does not include the approval of Bt-11 sweet...
BC Extra | Apr 27, 2004
Politics & Policy

EU agriculture ministers split on GM corn

The agriculture ministers of the EU members states did not approve for import the BT-11 genetically modified (GM) corn borer resistant sweet corn from Syngenta (SWX:SYNN; SYT), after voting 6-6 with 3 abstentions. An approval...
BC Week In Review | Oct 19, 1998
Clinical News

Novartis Seeds Inc. regulatory update

Switzerland granted marketing approval for Novartis' Bt-11 maize, which is resistant to the European corn borer, for use in food and animal feed. Novartis Seeds Inc., Golden Valley, Minn.   Business: Agbio/Veterinary/Environmental  ...
Items per page:
1 - 10 of 12